The "Global Healthcare Licensing: Monthly Report, Quarterly Report and Annual Trends" report has been added to ResearchAndMarkets.com's offering.

Global Healthcare Licensing: Monthly Report

As more and more progress in the life sciences sector occurs by a combination of different technologies, the growth of agreements implying activities of research and development, co-promoting and co-marketing has been strong. These licensing arrangements influence the healthcare markets and are therefore an important factor for consideration for companies for their healthcare investments. This monthly report brings at one place all such licensing deals and negotiations that takes place among global healthcare companies every month.

Key Features:

  • Global healthcare licensing transactions of each month at one place
  • Small, medium and big multinational/non-multinational companies covered
  • Curated categorizations of licensing details
  • 8+ variables reflecting different forms of transactions done
  • Licensing regulatory news updates

Global Healthcare Licensing: Quarterly Report

Japan, US and Europe are the world's largest healthcare markets. Patients in these regions have comparable buying power and they can rely on a widely available and high quality healthcare products. As more and more progress in the life sciences sector occurs by a combination of different technologies, the growth of agreements implying activities of research and development, co-promoting and co-marketing has been strong. These licensing arrangements influence the healthcare markets and are therefore an important factor for consideration for companies for their healthcare investments.

This quarterly report brings at one place all such licensing deals and negotiations that take place between healthcare companies of Japan, US and Europe every quarter. Further, the licensing deals and negotiations that take place between healthcare companies of other select regions with Japan, US and Europe as well as among the healthcare companies of Japan, US, Europe, and other select regions every quarter are also studied and included here. Moreover, all this collected data is comprehensively analyzed to understand the licensing trends and directions during each quarter in the healthcare segments.

Key Features:

  • 3 months' Japan-US-Europe healthcare licensing transactions at one place
  • 3 months' other select regions healthcare licensing transactions at one place
  • Small, medium and big multinational/non-multinational companies covered
  • Curated categorizations of licensing details
  • 8+ variables reflecting different forms of transactions done
  • Licensing regulatory news updates
  • Canada/Australia/NZ licensing trends with Japan-US-Europe covered
  • Emerging markets licensing trends with Japan-US-Europe covered
  • Licensing trends among Japan, US, Europe, and other select regions covered
  • Licensing trends and directions summarized

Global Healthcare Licensing: Annual Trends

Japan, US and Europe are the world's largest healthcare markets. Patients in these regions have comparable buying power and they can rely on a widely available and high quality healthcare products. As more and more progress in the life sciences sector occurs by a combination of different technologies, the growth of agreements implying activities of research and development as well as licensing for co-promoting and co-marketing has been strong. These licensing arrangements influence the healthcare markets and are therefore an important factor for consideration for companies for their healthcare investments.

This capstone research report brings at one place all such licensing deals and negotiations that take place between healthcare companies of Japan, US and Europe every year. Further, the licensing deals and negotiations that take place between healthcare companies of other select regions with Japan, US and Europe as well as among the healthcare companies of Japan, US, Europe, and other select regions every year are also studied and included here. Moreover, all this collected data is comprehensively analyzed to understand the licensing trends and directions during each year in the healthcare segments.

Key features:

  • 12 months' Japan-US-Europe healthcare licensing transactions at one place
  • 12 months' other select regions healthcare licensing transactions at one place
  • Small, medium and big multinational/non-multinational companies covered
  • Curated categorizations of licensing details
  • 8+ variables reflecting different forms of transactions done
  • Licensing regulatory news updates
  • Canada/Australia/NZ licensing trends with Japan-US-Europe covered
  • Emerging markets licensing trends with Japan-US-Europe covered
  • Licensing trends among Japan, US, Europe, and other select regions covered
  • Licensing trends and directions summarized

For more information about this report visit https://www.researchandmarkets.com/research/x5thfq/global_healthcare?w=4